Attomarker initiates Acceleration Round to scale immunology diagnostics platform
EXETER, UNITED KINGDOM, February 10, 2026 /EINPresswire.com/ -- Attomarker, a UK-based diagnostics company, today announced that it has commenced an Acceleration Round as it enters the next phase of its commercial and clinical development. Attomarker …